159 related articles for article (PubMed ID: 3487589)
1. Restriction of the human in vivo immune response against the mouse monoclonal antibody OKT3.
Chatenoud L; Baudrihaye MF; Chkoff N; Kreis H; Goldstein G; Bach JF
J Immunol; 1986 Aug; 137(3):830-8. PubMed ID: 3487589
[TBL] [Abstract][Full Text] [Related]
2. Unusually restricted anti-isotype human immune response to OKT3 monoclonal antibody.
Baudrihaye MF; Chatenoud L; Kreis H; Goldstein G; Bach JF
Eur J Immunol; 1984 Aug; 14(8):686-91. PubMed ID: 6381066
[TBL] [Abstract][Full Text] [Related]
3. Murine anti-mouse T cell monoclonal antibodies elicit anti-antibodies in mice: intra-species immunization model for estimating potential patient sensitization against humanized anti-T cell antibodies.
Kremmer E; Mysliwietz J; Lederer R; Thierfelder S
Eur J Immunol; 1993 May; 23(5):1017-22. PubMed ID: 8097469
[TBL] [Abstract][Full Text] [Related]
4. [In vivo use of OKT3 monoclonal antibodies in recipients of renal allografts].
Chatenoud L; Bach JF
Nephrologie; 1987; 8(3):95-8. PubMed ID: 3309702
[TBL] [Abstract][Full Text] [Related]
5. Human immune response to multiple injections of murine monoclonal IgG.
Shawler DL; Bartholomew RM; Smith LM; Dillman RO
J Immunol; 1985 Aug; 135(2):1530-5. PubMed ID: 3874237
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibody therapy. Anti-idiotypic and non-anti-idiotypic antibodies to OKT3 arising despite intense immunosuppression.
Jaffers GJ; Fuller TC; Cosimi AB; Russell PS; Winn HJ; Colvin RB
Transplantation; 1986 May; 41(5):572-8. PubMed ID: 3085297
[TBL] [Abstract][Full Text] [Related]
7. Fine specificity of antibodies produced in rhesus monkeys following in vivo treatment with anti-T cell murine monoclonal antibodies.
Villemain F; Jonker M; Bach JF; Chatenoud L
Eur J Immunol; 1986 Aug; 16(8):945-9. PubMed ID: 3527722
[TBL] [Abstract][Full Text] [Related]
8. Anti-CD4 and anti-CD2 monoclonal antibody infusions in subjects with multiple sclerosis. Immunosuppressive effects and human anti-mouse responses.
Hafler DA; Ritz J; Schlossman SF; Weiner HL
J Immunol; 1988 Jul; 141(1):131-8. PubMed ID: 2454256
[TBL] [Abstract][Full Text] [Related]
9. The OKT3 immunosuppressive effect. In situ antigenic modulation of human graft-infiltrating T cells.
Caillat-Zucman S; Blumenfeld N; Legendre C; Noel LH; Bach JF; Kreis H; Chatenoud L
Transplantation; 1990 Jan; 49(1):156-60. PubMed ID: 2137271
[TBL] [Abstract][Full Text] [Related]
10. Immunoglobulin class and immunoglobulin G subclass analysis of human anti-mouse antibody response during monoclonal antibody treatment of cancer patients.
Blottière HM; Douillard JY; Koprowski H; Steplewski Z
Cancer Res; 1990 Feb; 50(3 Suppl):1051s-1054s. PubMed ID: 2297720
[TBL] [Abstract][Full Text] [Related]
11. Immunologic monitoring during OKT3 therapy.
Chatenoud L
Clin Transplant; 1993 Aug; 7(4 Pt 2):422-30. PubMed ID: 10146352
[TBL] [Abstract][Full Text] [Related]
12. Structural characterization of an (NZB x NZW)F1 mouse-derived IgM monoclonal antibody that binds through V region-dependent interactions to murine IgG anti-DNA antibodies.
Margaritte C; Gilbert D; Brard F; Tron F
J Autoimmun; 1994 Dec; 7(6):711-25. PubMed ID: 7888030
[TBL] [Abstract][Full Text] [Related]
13. Anti-idiotypic antibodies to the third variable domain of gp120 induce an anti-HIV-1 antibody response in mice.
Boudet F; Theze J; Zouali M
Virology; 1994 Apr; 200(1):176-88. PubMed ID: 7510435
[TBL] [Abstract][Full Text] [Related]
14. Importance of antibody isotype in monoclonal anti-idiotype therapy of a murine B cell lymphoma. A study of hybridoma class switch variants.
Kaminski MS; Kitamura K; Maloney DG; Campbell MJ; Levy R
J Immunol; 1986 Feb; 136(3):1123-30. PubMed ID: 3484499
[TBL] [Abstract][Full Text] [Related]
15. [In vivo study of antitumor immune responses induced by anti-idiotypic minibody vaccine of ovarian cancer].
Chang XH; Cui H; Feng J; Yang WL; Li Y; Fu TY
Ai Zheng; 2004 Jul; 23(7):777-81. PubMed ID: 15248911
[TBL] [Abstract][Full Text] [Related]
16. Modulation of antigen-specific T cell response by a non-mitogenic anti-CD3 antibody.
Li J; Davis J; Bracht M; Carton J; Armstrong J; Gao W; Scallon B; Fung R; Emmell E; Zimmerman M; Griswold DE; Li L
Int Immunopharmacol; 2006 Jun; 6(6):880-91. PubMed ID: 16644473
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibodies against T cell differentiation antigens initiate stimulation of monocyte/macrophage oxidative metabolism.
Descamps-Latscha B; Golub RM; Nguyen AT; Feuillet-Fieux MN
J Immunol; 1983 Nov; 131(5):2500-7. PubMed ID: 6195264
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal anti-idiotype antibody bearing the internal image of nasopharyngeal carcinoma associated antigen.
Li G; Hu J; Zhou G; Zhu J; Sun Q
Chin Med J (Engl); 2001 Sep; 114(9):962-6. PubMed ID: 11780392
[TBL] [Abstract][Full Text] [Related]
19. Reexposure to OKT3 in renal allograft recipients.
Mayes JT; Thistlethwaite JR; Stuart JK; Buckingham MR; Stuart FP
Transplantation; 1988 Feb; 45(2):349-53. PubMed ID: 3278428
[TBL] [Abstract][Full Text] [Related]
20. Gangliosides, Ab1 and Ab2 antibodies III. The idiotype of anti-ganglioside mAb P3 is immunogenic in a T cell-dependent manner.
López-Requena A; Bestagno M; Mateo de Acosta C; Cesco-Gaspere M; Vázquez AM; Pérez R; Burrone OR
Mol Immunol; 2007 Apr; 44(11):2915-22. PubMed ID: 17316805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
